Harald Anderson
Impact in
-
- Lymphoma Diagnosis and Treatment
- Breast Lesions and Carcinomas
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 27
- Cancer Risks and Factors 5
-
- Lymphoma Diagnosis and Treatment 8
- Breast Lesions and Carcinomas 5
- Genetic factors in colorectal cancer 4
- Co-authors
- Jørgen H. Olsen (10 shared papers)Henrik Møller (9 shared papers)Håkan Olsson (6 shared papers)Stanislaw Garwicz (7 shared papers)Anita Ringberg (4 shared papers)Kerstin Sandelin (3 shared papers)Stefan O. Emdin (3 shared papers)Lars Holmberg (3 shared papers)
In The Last Decade
Harald Anderson
79 papers receiving 4.0k citations
Harald Anderson's Hit Papers
Peers
Comparison fields: 5 of 119
- Pathology and Forensic Medicine 970
- Cancer Research 770
- Radiation 431
- Oncology 1.3k
- Otorhinolaryngology 190
Countries citing papers authored by Harald Anderson
This map shows the geographic impact of Harald Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Anderson more than expected).
Fields of papers citing papers by Harald Anderson
This network shows the impact of papers produced by Harald Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Anderson. The network helps show where Harald Anderson may publish in the future.
Co-authors
The 25 scholars most cited alongside Harald Anderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial Hit paper breakdown → | 2019 | 559 |
| 2 | 2012 | 386 | |
| 3 | 2002 | 191 | |
| 4 | 2008 | 170 | |
| 5 | 2006 | 164 | |
| 6 | 2014 | 152 | |
| 7 | 2009 | 137 | |
| 8 | 2000 | 125 | |
| 9 | 1998 | 110 | |
| 10 | 1996 | 105 | |
| 11 | 2016 | 105 | |
| 12 | 1991 | 97 | |
| 13 | 2001 | 85 | |
| 14 | 1984 | 70 | |
| 15 | 2004 | 66 | |
| 16 | 2014 | 65 | |
| 17 | 2014 | 63 | |
| 18 | 1996 | 62 | |
| 19 | 1993 | 60 | |
| 20 | 2013 | 58 |
About Harald Anderson
Harald Anderson is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 79 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (12 papers), Childhood Cancer Survivors' Quality of Life (11 papers), Breast Cancer Treatment Studies (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Sarcoma Diagnosis and Treatment (8 papers), Breast Lesions and Carcinomas (5 papers), Cancer Risks and Factors (5 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (970 citations), Cancer Research (770 citations), Radiation (431 citations), Oncology (1.3k citations) and Otorhinolaryngology (190 citations). Harald Anderson has collaborated with scholars based in Sweden, Denmark and Finland. Frequent co-authors include Jørgen H. Olsen, Henrik Møller, Håkan Olsson, Stanislaw Garwicz, Anita Ringberg, Kerstin Sandelin, Stefan O. Emdin, Lars Holmberg, Lars-Gunnar Arnesson and Hans Garmo. Their work appears in journals such as Blood, European Journal of Cancer, Journal of Clinical Oncology, Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.